Latest EGRX reports update at 2023-08-08: 2023-Q22022-Q42022-Q2
Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 3.85 0.79%

Eagle Pharmaceuticals Deferred Revenue 2011-2024 | EGRX

Annual Deferred Revenue Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - - 6 M 6.58 M 10 M 9.5 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
10 M 6 M 8.03 M

Quarterly Deferred Revenue Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - 3.05 M 4.34 M 4.32 M 4.97 M 7.12 M 4.97 M 4.97 M 8.36 M 10.4 M 8.36 M 8.36 M 5.87 M - 5.87 M - - - - - - - - - 6 M 6 M 6 M 6 M 6.52 M 6.52 M 6.52 M 6.52 M - 10 M 10 M - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
10.4 M 3.05 M 6.57 M